Mass Balance Study of [14C]Chiauranib

NCT05371899 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Chiauranib

Sponsor

Chipscreen Biosciences, Ltd.